drugset
drugset / Trial / NCT00363753

Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

NCT00363753 ↗

Phase 1 Withdrawn University of California, San Diego
RandomizedParallel-groupOpen-labelPrevention

Summary

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

Timeline

Start
2006-08
Primary completion
—
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule — —
Subject Clopidogrel Small molecule — —

Indications

aspirin resistance transient ischemic attack